Skip to content
ClearReads

Individuals Discontinuing Anti-Obesity Injections Regain Pounds Far More Rapidly Than Those on Conventional Diets

Illustration of pharmaceutical syringe and scale
Obesity treatment often requires ongoing approaches.

New research suggests that individuals who stop using new slimming jabs like Wegovy and Mounjaro may regain reduced body mass far faster than those who stop traditional lifestyle regimens.

Findings released in a major medical journal shows that while overweight individuals often shed about a fifth of their body weight while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"Users using these drugs must be informed of the danger of quick weight regain when the medication concludes," cautioned expert Dr. Susan Jebb.

This pace of recovery suggests a reversion to pre-treatment weight within about one and a half years.

Comparing Approaches

The research, which reviewed 37 of studies involving over 9,000 of patients, compared the results of these new drugs with other pills.

Researchers note that individuals who shed pounds through diet and exercise usually experience a less rapid creep back—approximately 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Nutrition scientists believe the way of the jabs is key to understanding the heightened regain.

The injections imitate a body's own chemical called GLP-1, which helps regulate hunger.

"Sustained high doses of the hormone levels several times higher than the body's typical production could lead to the system to produce less of its endogenous hormone, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.

"Withdrawal of this hormone supplement results in appetite is unsuppressed, making excessive eating far more likely."

A Chronic Disease?

Medical guidelines suggest the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.

Professionals argue that, given the high risk of weight regain, the treatment should be considered ongoing.

This perspective is reinforced by drug manufacturers, who state that the findings "underscore the long-term nature of obesity," akin to managing diseases like hypertension.

Patient Experiences

Users who have discontinued the jabs report a powerful return of appetite.

"It was like a trigger activating and you become starving," recalled an individual.

This challenge is compounded if users have not established sustainable dietary or behavioural modifications during treatment.

Growing Interest

Recent estimates suggest that millions of people in the UK have tried these injections in the last 12 months, with demand being substantial.

  • Adoption is more common among females compared to males.
  • The 40s and 50s age group shows the highest usage rates.
  • Many obtain the drugs through private prescriptions rather than public health services.

Ultimately, researchers stress that while these medications are powerful tools for weight loss, they are not a magic solution and maintained weight loss hinges on ongoing behavioural support.

The writer

Amy Burke

A passionate bibliophile and literary critic with a background in English literature, dedicated to uncovering hidden gems in contemporary fiction.

ClearReads

Type to search articles.